Leaflet PARASINUS PENTA 500mg / 38mg / 5mg / 25mg / 20mg tablets


Indicated for: cold and flu symptoms

Substance: paracetamol + ascorbic acid + phenylephrine + caffeine + terpin hydrate (analgesic and antipyretic + xanthine stimulant + adrenergic decongestant + expectorant + vitamin)

ATC: N02BE51 (Nervous system | Other analgesics and antipyretics | Anilides)

Paracetamol, ascorbic acid, phenylephrine, caffeine, and terpin hydrate are active ingredients used in combination to treat cold and flu symptoms such as fever, headaches, nasal congestion, productive cough, and fatigue. This combination provides a comprehensive solution for relieving discomfort associated with respiratory infections.

Paracetamol is an analgesic and antipyretic that reduces pain and fever. Ascorbic acid (vitamin C) supports the immune system and helps reduce the duration of symptoms. Phenylephrine is a nasal decongestant that works by constricting blood vessels in the nasal mucosa, reducing inflammation and congestion. Caffeine acts as a stimulant, reducing fatigue and improving the absorption of analgesics. Terpin hydrate is an expectorant that helps thin mucus, making it easier to expel through coughing.

Although this combination is effective, its use should be approached with caution. Phenylephrine may cause insomnia, agitation, or increased blood pressure, especially in sensitive individuals. Caffeine may amplify these effects and can cause insomnia or palpitations. Terpin hydrate may cause stomach discomfort, while paracetamol, if overused, can harm the liver.

This combination is available over the counter, but patients should follow the recommended dosage and avoid long-term use. If symptoms persist for more than a few days or worsen, medical advice is necessary. Individuals with high blood pressure, cardiovascular diseases, or other chronic conditions should consult a doctor before use.

General data about PARASINUS PENTA 500mg / 38mg / 5mg / 25mg / 20mg

  • Substance: paracetamol + ascorbic acid + phenylephrine + caffeine + terpin hydrate
  • Date of last drug list: 01-05-2024
  • Commercial code: W70154001
  • Concentration: 500mg / 38mg / 5mg / 25mg / 20mg
  • Pharmaceutical form: tablets
  • Quantity: 12
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: GLAXO SMITHKLINE DUNGARVAN LIMITED - IRLANDA
  • Holder: HALEON ROMANIA S.R.L. - ROMANIA
  • Number: 1755/2009/01
  • Shelf life: 2 years